Mana Capital Acquisition (MAAQ) Competitors $0.25 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends MAAQ vs. OBSV, ATHE, COEP, GLTO, BIOR, SYRS, ABVC, BCLI, CANF, and EDSAShould you be buying Mana Capital Acquisition stock or one of its competitors? The main competitors of Mana Capital Acquisition include ObsEva (OBSV), Alterity Therapeutics (ATHE), Coeptis Therapeutics (COEP), Galecto (GLTO), Biora Therapeutics (BIOR), Syros Pharmaceuticals (SYRS), ABVC BioPharma (ABVC), Brainstorm Cell Therapeutics (BCLI), Can-Fite BioPharma (CANF), and Edesa Biotech (EDSA). These companies are all part of the "pharmaceutical products" industry. Mana Capital Acquisition vs. ObsEva Alterity Therapeutics Coeptis Therapeutics Galecto Biora Therapeutics Syros Pharmaceuticals ABVC BioPharma Brainstorm Cell Therapeutics Can-Fite BioPharma Edesa Biotech ObsEva (NASDAQ:OBSV) and Mana Capital Acquisition (NASDAQ:MAAQ) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends. Does the media favor OBSV or MAAQ? In the previous week, ObsEva had 1 more articles in the media than Mana Capital Acquisition. MarketBeat recorded 1 mentions for ObsEva and 0 mentions for Mana Capital Acquisition. ObsEva's average media sentiment score of 0.00 equaled Mana Capital Acquisition'saverage media sentiment score. Company Overall Sentiment ObsEva Neutral Mana Capital Acquisition Neutral Is OBSV or MAAQ more profitable? Mana Capital Acquisition's return on equity of 0.00% beat ObsEva's return on equity.Company Net Margins Return on Equity Return on Assets ObsEvaN/A -416.36% -92.01% Mana Capital Acquisition N/A N/A N/A Does the MarketBeat Community believe in OBSV or MAAQ? ObsEva received 318 more outperform votes than Mana Capital Acquisition when rated by MarketBeat users. However, 100.00% of users gave Mana Capital Acquisition an outperform vote while only 51.45% of users gave ObsEva an outperform vote. CompanyUnderperformOutperformObsEvaOutperform Votes31951.45% Underperform Votes30148.55% Mana Capital AcquisitionOutperform Votes1100.00% Underperform VotesNo Votes Which has better valuation & earnings, OBSV or MAAQ? Mana Capital Acquisition has lower revenue, but higher earnings than ObsEva. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioObsEva$20.11M0.00-$58.38M-$0.92N/AMana Capital AcquisitionN/AN/AN/AN/AN/A Do insiders & institutionals have more ownership in OBSV or MAAQ? 17.5% of ObsEva shares are held by institutional investors. Comparatively, 68.4% of Mana Capital Acquisition shares are held by institutional investors. 14.4% of ObsEva shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryObsEva and Mana Capital Acquisition tied by winning 4 of the 8 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Mana Capital Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for MAAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MAAQ vs. The Competition Export to ExcelMetricMana Capital AcquisitionIn Vitro, In Vivo Diagnostic Substances IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$2.01M$2.01M$109.25M$8.84BDividend YieldN/AN/A5.20%4.07%P/E RatioN/AN/A1.0717.61Price / SalesN/AN/A1.2586.52Price / CashN/AN/A100.1736.27Price / BookN/AN/A519.866.36Net IncomeN/AN/A$2.46M$226.00M7 Day Performance-19.62%-19.62%-0.46%-0.03%1 Month Performance7.10%7.10%-2.94%1.96%1 Year Performance-75.01%-75.01%15.94%27.78% Mana Capital Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MAAQMana Capital AcquisitionN/A$0.25flatN/A-73.7%$2.01MN/A0.001High Trading VolumeOBSVObsEvaN/AN/AN/AN/A$7.94M$20.11M-0.1150ATHEAlterity Therapeutics3.1714 of 5 stars$1.07+1.9%$4.00+273.8%N/A$7.81MN/A0.0010Gap UpCOEPCoeptis TherapeuticsN/A$0.19flatN/A-83.3%$7.81M$80,000.00-0.652GLTOGalecto3.1258 of 5 stars$5.85+0.7%$10.00+71.1%-60.6%$7.72MN/A-0.3140BIORBiora Therapeutics2.6028 of 5 stars$1.63+0.6%$23.00+1,311.0%-87.9%$7.37MN/A-0.12120Analyst ForecastSYRSSyros Pharmaceuticals4.1006 of 5 stars$0.27-6.9%$3.33+1,134.6%-89.9%$7.24M$9.94M-0.09120Analyst RevisionHigh Trading VolumeABVCABVC BioPharma0.7456 of 5 stars$0.55-3.5%N/A-66.4%$7.14M$150,000.00-0.6630Gap UpBCLIBrainstorm Cell Therapeutics4.4621 of 5 stars$1.24-1.6%$30.00+2,319.4%-53.4%$7.07MN/A-0.2640Analyst UpgradePositive NewsCANFCan-Fite BioPharma1.8751 of 5 stars$1.97-2.0%$18.00+813.7%-1.7%$6.97M$740,000.00-1.138Analyst DowngradeNews CoverageEDSAEdesa Biotech3.1614 of 5 stars$2.11-4.1%$21.00+895.3%-27.9%$6.86MN/A0.0020Gap Down Related Companies and Tools Related Companies OBSV Alternatives ATHE Alternatives COEP Alternatives GLTO Alternatives BIOR Alternatives SYRS Alternatives ABVC Alternatives BCLI Alternatives CANF Alternatives EDSA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MAAQ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mana Capital Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mana Capital Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
